JP2014511365A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014511365A5 JP2014511365A5 JP2013551325A JP2013551325A JP2014511365A5 JP 2014511365 A5 JP2014511365 A5 JP 2014511365A5 JP 2013551325 A JP2013551325 A JP 2013551325A JP 2013551325 A JP2013551325 A JP 2013551325A JP 2014511365 A5 JP2014511365 A5 JP 2014511365A5
- Authority
- JP
- Japan
- Prior art keywords
- isopropylamino
- propoxy
- hydroxy
- methyl
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161436995P | 2011-01-27 | 2011-01-27 | |
| US61/436,995 | 2011-01-27 | ||
| PCT/US2012/022679 WO2012103305A1 (en) | 2011-01-27 | 2012-01-26 | Use of (s) - esmolol for controlling venous irritation associated with the treatment of a cardiac disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014511365A JP2014511365A (ja) | 2014-05-15 |
| JP2014511365A5 true JP2014511365A5 (enExample) | 2015-03-19 |
Family
ID=45567140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013551325A Withdrawn JP2014511365A (ja) | 2011-01-27 | 2012-01-26 | 心臓障害の処置に関連する静脈刺激を調節するための（ｓ）−エスモロールの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8829047B2 (enExample) |
| EP (1) | EP2667866B1 (enExample) |
| JP (1) | JP2014511365A (enExample) |
| KR (1) | KR20140019334A (enExample) |
| CN (1) | CN103347513A (enExample) |
| AU (1) | AU2012211309B2 (enExample) |
| BR (1) | BR112013018598A2 (enExample) |
| CA (1) | CA2825716A1 (enExample) |
| MX (1) | MX2013008715A (enExample) |
| WO (1) | WO2012103305A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2825311A1 (en) | 2011-01-27 | 2012-08-02 | Baxter International Inc. | Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension |
| US10813630B2 (en) | 2011-08-09 | 2020-10-27 | Corquest Medical, Inc. | Closure system for atrial wall |
| US10314594B2 (en) | 2012-12-14 | 2019-06-11 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US10307167B2 (en) | 2012-12-14 | 2019-06-04 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US20140142689A1 (en) | 2012-11-21 | 2014-05-22 | Didier De Canniere | Device and method of treating heart valve malfunction |
| US9566443B2 (en) | 2013-11-26 | 2017-02-14 | Corquest Medical, Inc. | System for treating heart valve malfunction including mitral regurgitation |
| US10842626B2 (en) | 2014-12-09 | 2020-11-24 | Didier De Canniere | Intracardiac device to correct mitral regurgitation |
| CA3244889A1 (en) | 2022-03-08 | 2023-09-14 | Equashield Medical Ltd | FLUID TRANSFER STATION IN A ROBOTIC PHARMACEUTICAL PREPARATION SYSTEM |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3584560D1 (de) | 1984-04-09 | 1991-12-05 | Du Pont | Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen. |
| EP0248879A4 (en) * | 1985-12-04 | 1990-02-26 | Du Pont | PRODUCTION OF ARYLOXYPROPANOLAMINES AND ARYLÄTHANOLAMINES. |
| WO1988001614A1 (en) | 1986-09-02 | 1988-03-10 | E.I. Du Pont De Nemours And Company | RESOLUTION OF dl-METHYL 3-[4-(2-HYDROXY-3-ISOPROPYLAMINO)PROPOXY]PHENYLPROPIONATE [(dl-ESMOLOL)] |
| US4857552A (en) | 1988-06-08 | 1989-08-15 | E. I. Du Pont De Nemours And Co. | Stable pharmaceutical composition |
| US5998019A (en) | 1993-11-16 | 1999-12-07 | Baxter International Inc. | Multi-layered polymer structure for medical products |
| US5849843A (en) | 1993-11-16 | 1998-12-15 | Baxter International Inc. | Polymeric compositions for medical packaging and devices |
| US5977409A (en) * | 1997-04-15 | 1999-11-02 | University Of Toledo | Method of using α-substituted benzylamine chiral auxiliary synthetic reagents |
| TWI277414B (en) * | 2001-01-12 | 2007-04-01 | Baxter Int | Esmolol formulation |
| US6310094B1 (en) * | 2001-01-12 | 2001-10-30 | Baxter International Inc. | Ready-to-use esmolol solution |
| US20060286037A1 (en) | 2003-08-08 | 2006-12-21 | Ono Pharmaceutical Co., Ltd. | Heart-slowing drug containing short-acting ß blocker as the active ingredient |
| US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
| CN101323580A (zh) | 2008-07-25 | 2008-12-17 | 河北科技大学 | 手性芳氧丙醇胺类化合物及其盐的合成方法 |
| CN101881755B (zh) | 2009-05-04 | 2013-05-29 | 南京海辰药业有限公司 | 通过高效液相色谱法检测盐酸艾司洛尔光学异构体的方法 |
| CN101891636A (zh) | 2009-05-21 | 2010-11-24 | 南京海辰药业有限公司 | 制备盐酸艾司洛尔光学异构体的新方法 |
| CN102106846A (zh) | 2009-12-23 | 2011-06-29 | 南京海辰药业有限公司 | 左旋盐酸艾司洛尔药物组合物及其制备方法 |
| CA2825311A1 (en) | 2011-01-27 | 2012-08-02 | Baxter International Inc. | Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension |
-
2012
- 2012-01-26 AU AU2012211309A patent/AU2012211309B2/en not_active Ceased
- 2012-01-26 JP JP2013551325A patent/JP2014511365A/ja not_active Withdrawn
- 2012-01-26 CA CA2825716A patent/CA2825716A1/en not_active Abandoned
- 2012-01-26 US US13/358,949 patent/US8829047B2/en active Active
- 2012-01-26 WO PCT/US2012/022679 patent/WO2012103305A1/en not_active Ceased
- 2012-01-26 MX MX2013008715A patent/MX2013008715A/es active IP Right Grant
- 2012-01-26 CN CN2012800067439A patent/CN103347513A/zh active Pending
- 2012-01-26 BR BR112013018598A patent/BR112013018598A2/pt not_active IP Right Cessation
- 2012-01-26 KR KR1020137022490A patent/KR20140019334A/ko not_active Withdrawn
- 2012-01-26 EP EP20120702940 patent/EP2667866B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014511365A5 (enExample) | ||
| TWI434688B (zh) | 選擇性ｓ１ｐ1受體激動劑之投藥療程 | |
| JP4683920B2 (ja) | Ｇｅｒｄの治療のためのｍｇｌｕｒ５アンタゴニストの使用 | |
| JP2014528474A5 (enExample) | ||
| Lien et al. | Perioperative hypertension: defining at-risk patients and their management | |
| JP2019504012A5 (enExample) | ||
| RU2014109074A (ru) | ИНГИБИТОРЫ ФАННИ-ТОКА (If), ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ПРИМЕНЕНИЯ В СПОСОБЕ ЛЕЧЕНИЯ И ПРЕДУПРЕЖДЕНИЯ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ У КОШАЧЬИХ | |
| JP2015526458A5 (enExample) | ||
| JP2019515908A5 (enExample) | ||
| RU2014141893A (ru) | Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2018531938A5 (enExample) | ||
| JP5643213B2 (ja) | 肥大性心筋症治療用のホスホジエステラーゼタイプＩＩＩ（ＰＤＥＩＩＩ）インヒビターまたはＣａ２＋感作剤 | |
| CA2906196A1 (en) | Enantiomerically enriched s-oxprenolol compositions for treating cancer | |
| EP2988750B9 (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| JP2016507500A5 (enExample) | ||
| JP2020510043A5 (enExample) | ||
| RU2013112890A (ru) | Терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина | |
| US20160045527A1 (en) | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist | |
| JP2016510040A5 (enExample) | ||
| WO2010110428A1 (ja) | 掻痒の予防及び／または治療剤 | |
| WO2014014706A1 (en) | Nicotinamide derivate in the treatment of acute coronary syndrome | |
| TW201206432A (en) | Association of xanthine oxidase inhibitors and angiotensin II receptor antagonists and use thereof | |
| JP2019517474A5 (enExample) | ||
| WO2017121432A1 (en) | Tesofensine and metoprolol for treatment of hypertension |